Notable Guests
AT
Alex Tatem
1x
BB
Brian Birnbaum
1x
CA
Christian Angermayer
1x
DM
David Maris
1x
DW
David Wells
1x
ED
Eli Dorf
1x
IC
Ignacio Canto
1x
IK
Imran Khan
1x
JM
Jesse Morse
1x
JL
Jonah Lupton
1x
MH
Mansi Hukmani
1x
MM
Maximilian Martin
1x
RM
Ryan MacDonald
1x
SC
Sagar Chopra
1x
Recent Episodes
✨
Enhanced Games CEO Jonathan Stern discusses the upcoming games and telehealth platform.
✨
Dr. Alex Tatem shares his experience testifying before the FDA on peptides.
Alex Tatem
✨
Dr. Jesse Morse discusses the FDA's upcoming peptide review and market impact.
Jesse Morse
✨
Analyst Ryan MacDonald estimates the peptide market could exceed $30 billion.
✨
Board member David Wells explains his $1.2M Hims share purchase.
✨
Hedge fund manager Ignacio Canto views Hims as a 'Costco + Netflix' model.
✨
Hedge fund manager Imran Khan bought Hims shares during a market downturn.
Imran Khan
✨
Researcher Cremieux estimates half of America could be on GLP-1s by 2030.
✨
Empower Sleep founders discuss AI-powered sleep care solutions.
Sagar Chopra
Sahil Chopra
✨
Eli Dorf explains how Bask Health enables rapid telehealth startup launches.
Eli Dorf
✨
Brian Birnbaum analyzes Hims & Hers Q1 earnings and the bull case.
Brian Birnbaum
✨
Mansi Hukmani explores the growing peptide culture and telehealth frontier.
Mansi Hukmani
✨
Enhanced Games co-founders discuss their approach to PEDs and upcoming games.
Christian Angermayer
Max Martin
✨
Analyst David Maris revisits Hims' GLP-1 timeline and Novo partnership.
David Maris
✨
Jonah Lupton presents his bullish case for Hims & Hers, focusing on peptides.
Jonah Lupton